ReviewKorean circulation journal2020
Percutaneous Edge-to-Edge Mitral Valve Repair.
Review in Korean circulation journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 7 citations in OpenAlex.
- A Whole-Heart Fluid-Structure Interaction Model for Transcatheter Mitral Valve Repair in Primary Mitral Regurgitation.Annals of biomedical engineering · 2026Article
- Technologies in minimally invasive treatment of severe mitral regurgitation.Cardiology journal · 2026Review
- Epidemiology of Valvular Heart Disease in Asia Pacific Region.JACC. Asia · 2025Review
- Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature.Cardiology journal · 2023Review
- Can Multidetector Computed Tomographic Angiography Replace Transesophageal Echocardiography for Preoperative Transcatheter Edge-to-Edge Mitral Valve Repair Planning Purposes?Journal of cardiovascular imaging · 2023Article
- Complications Following MitraClip Implantation.Current cardiology reports · 2021Review
- Economic Burden of Heart Failure in Asian Countries Based on Real-world Data.Korean circulation journal · 2021Article
- Recent Evidence and Initial Experiences of Transcatheter Edge-to-Edge Repair of the Mitral Valve in South Korea.Journal of chest surgery · 2021Article
- Transcatheter Mitral Valve Repair with MitraClipHeart views : the official journal of the Gulf Heart AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous edge-to-edge mitral valve repair, using the MitraClip device for severe mitral regurgitation (MR) was first introduced in 2003. Since then, more than 100,000 cases have been performed worldwide and it remains the most established percutaneous therapy available for the treatment of severe MR. Currently, it is indicated for severe, symptomatic functional MR in patients who continue to have significant symptoms despite optimal guideline directed medical therapy, as well as in symptomatic patients with severe degenerative MR who are deemed too high risk for conventional surgical therapy in the opinion of the heart team. In this paper, we discuss the evolution of the MitraClip device, the clinical studies supporting its use as well as the important concept of proportionate and disproportionate MR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.